Pancreatic Cancer Research

ResearcherOsaka Medical and Pharmaceutical UniversityActive in the last 2 years

Atsushi Tomioka

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7008-1502; OpenAlex author ID A5064296815. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 3 papers

Papers 8

  1. International multicenter validation of an 18F-fluorodeoxyglucose positron emission tomography/computed tomography maximum standardized uptake value 4.0 thresh… Co-author DOI 10.1016/j.surg.2026.110503↗
  2. Relationship Between PTBP1 and Pancreatic Cancer Based on microRNA and Behavior During TYMS-Mediated Carcinogenesis. Co-author DOI 10.1111/cas.70402↗
  3. Rapid Development of Diffuse-Type Remnant Pancreatic Cancer Following Obstructive Pancreatitis after Pancreaticoduodenectomy for Distal Bile Duct Carcinoma: A … Co-author DOI 10.70352/scrj.cr.25-0715↗
  4. Combined resection of the gastroduodenal artery without revascularization in distal pancreatectomy with en bloc celiac axis resection (extended DP-CAR) for pan… Co-author DOI 10.1016/j.ijscr.2022.107803↗
  5. Association Between Neoadjuvant Chemoradiotherapy and Intractable Serous Ascites After Pancreaticoduodenectomy for Pancreatic Cancer. Co-author DOI 10.1245/s10434-020-09401-w↗
  6. ASO Author Reflections: Association Between Neoadjuvant Chemoradiotherapy and Intractable Serous Ascites After Pancreaticoduodenectomy for Pancreatic Cancer. Co-author DOI 10.1245/s10434-020-09413-6↗
  7. Lymphocyte-to-Monocyte Ratio and Prognostic Nutritional Index Predict Poor Prognosis in Patients on Chemotherapy for Unresectable Pancreatic Cancer. Co-author DOI 10.21873/anticanres.13331↗
  8. Span-1 and CA19-9 as Predictors of Early Recurrence and Lymph Node Metastasis for Patients with Invasive Pancreatic Cancer after Pancreatectomy. Co-author DOI 10.1177/000313481808400130↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sang‐Woong Lee · 3 shared papers, 2023–2026 · strength 0.74
  2. Kazuhisa Uchiyama · 4 shared papers, 2018–2021 · strength 0.61
  3. Tetsunosuke Shimizu · 4 shared papers, 2018–2023 · strength 0.55
  4. Shigenori Suzuki · 1 shared paper, 2026 · strength 0.25
  5. Isamu Makino · 1 shared paper, 2026 · strength 0.19
  6. Teiichi Sugiura · 1 shared paper, 2026 · strength 0.19
  7. Shintaro Yagi · 1 shared paper, 2026 · strength 0.19
  8. Yoo‐Seok Yoon · 1 shared paper, 2026 · strength 0.19
  9. Tetsuya Idichi · 1 shared paper, 2026 · strength 0.19
  10. Kousei Ishigami · 1 shared paper, 2026 · strength 0.19
  11. Hongbeom Kim · 1 shared paper, 2026 · strength 0.19
  12. Hyung Il Seo · 1 shared paper, 2026 · strength 0.19
  13. Shigeru Marubashi · 1 shared paper, 2026 · strength 0.19
  14. Naru Kim · 1 shared paper, 2026 · strength 0.19
  15. Minoru Oshima · 1 shared paper, 2026 · strength 0.19
  16. Munseok Choi · 1 shared paper, 2026 · strength 0.19
  17. Masayuki Tanaka · 1 shared paper, 2026 · strength 0.19
  18. Katsuhisa Ohgi · 1 shared paper, 2026 · strength 0.19
  19. Yoon Soo Chae · 1 shared paper, 2026 · strength 0.19
  20. Etsuro Hatano · 1 shared paper, 2026 · strength 0.19
  21. Shingo Baba · 1 shared paper, 2026 · strength 0.19
  22. Naoki Ikenaga · 1 shared paper, 2026 · strength 0.19
  23. Satoshi Hirano · 1 shared paper, 2026 · strength 0.19
  24. Tsutomu Fujii · 1 shared paper, 2026 · strength 0.19
  25. Wooil Kwon · 1 shared paper, 2026 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.